Stay updated with breaking news from Andrew Pecora. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New hope may be on the horizon for melanoma patients, as Moderna has announced promising results for its new skin cancer vaccine, which is now entering Phase III trials.
New hope may be on the horizon for melanoma patients, as Moderna has announced promising results for its new skin cancer vaccine, which is now entering Phase III trials.
Researchers from leading cancer institutions have shown that using a new mRNA vaccine, can significantly reduce the likelihood of melanoma
One in five people in the U.S. will develop skin cancer by the time they are 70 years old, making it the most common type of cancer.
Health experts say even though statistics show fair-skinned people are more likely to develop skin cancer, darker-skinned people are more likely to die from it.